SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-274438
Filing Date
2024-12-10
Accepted
2024-12-10 17:28:29
Documents
16
Period of Report
2024-12-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d883742d8k.htm   iXBRL 8-K 59179
2 EX-99.1 d883742dex991.htm EX-99.1 11591
6 GRAPHIC g883742g35s84.jpg GRAPHIC 33083
7 GRAPHIC g883742g97a68.jpg GRAPHIC 128929
  Complete submission text file 0001193125-24-274438.txt   572691

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ibrx-20241210.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibrx-20241210_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibrx-20241210_pre.xml EX-101.PRE 10821
18 EXTRACTED XBRL INSTANCE DOCUMENT d883742d8k_htm.xml XML 3501
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 241539488
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)